A new equation to estimate muscle mass from creatinine and cystatin C

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Kim, Sun Wook ^a,b   Jung, Hee Won ^a,c   Kim, Cheol Ho ^a,b   Kim, Kwang Il ^a,b   Chin, Ho Jun ^a,b   Lee, Hajeong ^b,d  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYSTATIN C;

ADULT; AGED; ARTICLE; BONE MASS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT MASS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MEDICAL EXAMINATION; MUSCLE MASS; PROTEIN BLOOD LEVEL; TERTIARY CARE CENTER; VERY ELDERLY; ADIPOSE TISSUE; BIOLOGICAL MODEL; BLOOD; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; SARCOPENIA; SKELETAL MUSCLE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; RETROSPECTIVE STUDIES; SARCOPENIA;

EID: 84959421495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148495     Document Type: Article

References (38)

1. Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept. J Am Geriatr Soc 2007; 55(5):780-91. doi: 10.1111/j.1532-5415.2007.01156.x .
2. Cawthon PM, Marshall LM, Michael Y, Dam TT, Ensrud KE, Barrett-Connor E, et al. Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc 2007; 55(8):1216-23. doi: 10.1111/j.1532-5415.2007.01259.x .
3. Oterdoom LH, Gansevoort RT, Schouten JP, de Jong PE, Gans RO, Bakker SJ. Urinary creatinine excretion, an indirect measure of muscle mass, is an independent predictor of cardiovascular disease and mortality in the general population. Atherosclerosis. 2009; 207(2):534-40. doi: 10.1016/j. atherosclerosis.2009.05.010 .
4. Srikanthan P, Karlamangla AS. Muscle mass index as a predictor of longevity in older adults. Am J Med 2014; 127(6):547-53. doi: 10.1016/j.amjmed.2014.02.007 .
5. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age ageing. 2010; 39(4):412-23. doi: 10.1093/ageing/afq034 .
6. Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014; 15(2):95-101. doi: 10.1016/j.jamda.2013.11.025 .
7. Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr 1983; 37(3):478-94. .
8. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol 1999; 277(3):E489-95. .
9. Engstrom CM, Loeb GE, Reid JG, Forrest WJ, Avruch L. Morphometry of the human thigh muscles. A comparison between anatomical sections and computer tomographic and magnetic resonance images. J Anat 1991; 176:139-56. .
10. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 1998; 85(1):115-22. .
11. Heymsfield SB, Smith R, Aulet M, Bensen B, Lichtman S, Wang J, et al. Appendicular skeletal muscle mass: measurement by dual-photon absorptiometry. Am J Clin Nutr 1990; 52(2):214-8. .
12. Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000; 89(2):465-71. .
13. Chien M-Y, Huang T-Y, Wu Y-T. Prevalence of Sarcopenia Estimated Using a Bioelectrical Impedance Analysis Prediction Equation in Community-Dwelling Elderly People in Taiwan. J Am Geriatr Soc 2008; 56(9):1710-5. doi: 10.1111/j.1532-5415.2008.01854.x .
14. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Manuel Gomez J, et al. Bioelectrical impedance analysis-part II: utilization in clinical practice. Clin Nutr 2004; 23(6):1430-53. doi: 10.1016/j. clnu.2004.09.012 .
15. Trutschnigg B, Kilgour RD, Reinglas J, Rosenthall L, Hornby L, Morais JA, et al. Precision and reliability of strength (Jamar vs. Biodex handgrip) and body composition (dual-energy X-ray absorptiometry vs. bioimpedance analysis) measurements in advanced cancer patients. Appl Physiol Nutr Metab 2008; 33 (6):1232-9. doi: 10.1139/H08-122 .
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130(6):461-70. doi: 10.7326/0003-4819-130-6-199903160-00002 .
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006 .
18. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75(6):652-60. doi: 10.1038/ki.2008.638 .
19. Goldberg TH, Finkelstein MS. Difficulties in estimating glomerular filtration rate in the elderly. Arch Intern Med 1987; 147(8):1430-3. doi: 10.1001/archinte.1987.00370080066014 .
20. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J kidney Dis 2000; 36(1):29-34. doi: 10.1053/ajkd.2000.8237 .
21. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157(7):471-81. doi: 10. 7326/0003-4819-157-7-201210020-00003 .
22. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-Analysis. Am J kidney Dis 2002; 40(2):221-6. doi: 10.1053/ajkd.2002.34487 .
23. Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr 2002; 76(2):378-83. .
24. Chew-Harris JS, Florkowski CM, George PM, Elmslie JL, Endre ZH. The relative effects of fat versus muscle mass on cystatin C and estimates of renal function in healthy young men. Ann Clin Biochem 2013; 50(Pt 1):39-46. doi: 10.1258/acb.2012.011241 .
25. Horber FF, Gruber B, Thomi F, Jensen EX, Jaeger P. Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition 1997; 13(6):524-34. doi: 10.1016/S0899-9007(97) 00031-2 .
26. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476):307-10. doi: 10.1016/S0140-6736(86)90837-8 .
27. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367(1):20-9. doi: 10.1056/NEJMoa1114248 .
28. Baxmann AC, Ahmed MS, Marques NC, Menon VB, Pereira AB, Kirsztajn GM, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol 2008; 3(2):348-54. doi: 10.2215/CJN.02870707 .
29. Muntner P, Winston J, Uribarri J, Mann D, Fox CS. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008; 121(4):341-8. doi: 10.1016/j.amjmed.2008.01. 003 .
30. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65(4):1416-21. doi: 10.1111/j.1523-1755.2004.00517.x .
31. Kottgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J. Serum cystatin C in the United States: The Third National Health and Nutrition Examination Survey (NHANES III). Am J kidney Dis 2008; 51(3):385-94. doi: 10.1053/j.ajkd.2007.11.019 .
32. Naour N, Fellahi S, Renucci JF, Poitou C, Rouault C, Basdevant A, et al. Potential contribution of adipose tissue to elevated serum cystatin C in human obesity. Obesity 2009; 17(12):2121-6. doi: 10.1038/oby.2009.96 .
33. Wasén E, Isoaho R, Mattila K, Vahlberg T, Kivelä S-L, Irjala K. Serum cystatin C in the aged: relationships with health status. Am J Kidney Dis 2003; 42(1):36-43. doi: 10.1016/s0272-6386(03)00406-2 .
34. Hart A, Paudel ML, Taylor BC, Ishani A, Orwoll ES, Cawthon PM, et al. Cystatin C and frailty in older men. J Am Geriatr Soc 2013; 61(9):1530-6. doi: 10.1111/jgs.12413 .
35. Odden MC, Chertow GM, Fried LF, Newman AB, Connelly S, Angleman S, et al. Cystatin C and measures of physical function in elderly adults: The Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol 2006; 164(12):1180-9. doi: 10.1093/aje/kwj333 .
36. Shlipak MG, Wassel Fyr CL, Chertow GM, Harris TB, Kritchevsky SB, Tylavsky FA, et al. Cystatin C and mortality risk in the elderly: The health, aging, and body composition study. J Am Soc Nephrol 2006; 17(1):254-61. doi: 10.1681/ASN.2005050545 .
37. Lake KD, Peterson CD. A Simplified Dosing Method for Initiating Vancomycin Therapy. Pharmacotherapy 1985; 5(6):340-4. doi: 10.1002/j.1875-9114.1985.tb03441.x .
38. Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, et al. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: A cohort study. Crit Care 2014; 18(3):R110. doi: 10.1186/cc13899